መነሻ › በርኪት ሊምፎማ
በአሜሪካ ለበርኪት ሊምፎማ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለበርኪት ሊምፎማ የሚደረጉ 63 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Houston, TX21 ጥናቶች
- Milwaukee, WI16 ጥናቶች
- Philadelphia, PA16 ጥናቶች
- New York City, NY14 ጥናቶች
- Chicago, IL14 ጥናቶች
- Cincinnati, OH12 ጥናቶች
- Atlanta, GA12 ጥናቶች
- Seattle, WA11 ጥናቶች
- Durham, NC10 ጥናቶች
- Boston, MA10 ጥናቶች
- Los Angeles, CA10 ጥናቶች
- Aurora, CO10 ጥናቶች
- Kansas City, MO10 ጥናቶች
- Orange, CA9 ጥናቶች
- Washington, DC9 ጥናቶች
- Minneapolis, MN9 ጥናቶች
- Baldwin Park, CA9 ጥናቶች
- Columbus, OH8 ጥናቶች
- Portland, OR8 ጥናቶች
- Buffalo, NY8 ጥናቶች
- Ann Arbor, MI8 ጥናቶች
- Baltimore, MD8 ጥናቶች
- San Francisco, CA8 ጥናቶች
- Nashville, TN8 ጥናቶች
- Tampa, FL7 ጥናቶች
- Clifton, NJ7 ጥናቶች
- Providence, RI7 ጥናቶች
- Dallas, TX7 ጥናቶች
- Richmond, VA7 ጥናቶች
- Jacksonville, FL7 ጥናቶች
- Greenburgh, NY7 ጥናቶች
- Birmingham, AL7 ጥናቶች
- Cleveland, OH7 ጥናቶች
- San Antonio, TX7 ጥናቶች
- Oklahoma City, OK7 ጥናቶች
- Grand Rapids, MI7 ጥናቶች
- Salt Lake City, UT7 ጥናቶች
- The Bronx, NY6 ጥናቶች
- Mountain View, CA6 ጥናቶች
- Charlotte, NC6 ጥናቶች
በክልል
- New Jersey8 ጥናቶች
- New Mexico3 ጥናቶች
- New York20 ጥናቶች
- North Carolina13 ጥናቶች
- North Dakota5 ጥናቶች
- Ohio17 ጥናቶች
- Oklahoma7 ጥናቶች
- Oregon8 ጥናቶች
- Pennsylvania18 ጥናቶች
- Rhode Island7 ጥናቶች
- South Carolina5 ጥናቶች
- South Dakota5 ጥናቶች
- Tennessee10 ጥናቶች
- Texas24 ጥናቶች
- Utah7 ጥናቶች
- Vermont3 ጥናቶች
- Virginia7 ጥናቶች
- Washington11 ጥናቶች
- West Virginia3 ጥናቶች
- Wisconsin17 ጥናቶች
- ሃዋይ5 ጥናቶች
- ሉዊዚያና4 ጥናቶች
- ሚሲሲፒ4 ጥናቶች
- ሚሺጋን10 ጥናቶች
- ሚኔሶታ10 ጥናቶች
- ሚዙሪ8 ጥናቶች
- ማሳቹሴትስ10 ጥናቶች
- ሜሪላንድ11 ጥናቶች
- ሜይን4 ጥናቶች
- ኒብራስካ5 ጥናቶች
- ኒው ሃምፕሻየር4 ጥናቶች
- ኔቫዳ6 ጥናቶች
- አላባማ7 ጥናቶች
- አሪዞና7 ጥናቶች
- አርካንሳስ5 ጥናቶች
- አይዳሆ6 ጥናቶች
- አዮዋ7 ጥናቶች
- ኢሊኖይ14 ጥናቶች
- ኢንዲያና6 ጥናቶች
- ከንታኪ5 ጥናቶች
- ካሊፎርኒያ20 ጥናቶች
- ካንሳስ6 ጥናቶች
- ኮሎራዶ13 ጥናቶች
- ኮነቲከት7 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ5 ጥናቶች
- ዴላዌር7 ጥናቶች
- ጆርጂያ12 ጥናቶች
- ፍሎሪዳ15 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
ተሳታዮችን በመፈለግ ላይደረጃ 2
366 Days – 46 Years · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03150693Blinatumomab Consolidation in Real World
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07117136Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05442515Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03739814Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT03223610Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06144606Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07223021Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
6 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06395103A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ0 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06173518UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
31 Days – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04544592Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT03666000A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT04546399Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05389423Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT06710418Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT06137118AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT06340737Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06287229Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 15 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT03136146Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ13 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06533579ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።